Firefly Neuroscience (AIFF) Payables (2010 - 2026)

Firefly Neuroscience has reported Payables for 16 years, with the latest figure at $881000.0 in Q2 2026.

• On a quarterly basis, Payables fell 41.34% year-over-year to $881000.0 in Q2 2026; TTM through Jun 2026 was $881000.0, a 41.34% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 49.04% from the prior year.
• Payables was $881000.0 for Q2 2026 at Firefly Neuroscience, down from $1.3 million in the prior quarter.
• The five-year high for Payables was $2.6 million in Q4 2024, with the low at $227560.0 in Q3 2022.
• Average Payables over 5 years is $1.1 million, with a median of $953413.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Payables slumped 86.8% in 2022, then soared 319.52% in 2024.
• Over 5 years, Payables stood at $573789.0 in 2022, then climbed by 9.8% to $630000.0 in 2023, then jumped by 319.52% to $2.6 million in 2024, then slumped by 49.04% to $1.3 million in 2025, then tumbled by 34.6% to $881000.0 in 2026.
• The last three Payables figures came in at $881000.0 (Q2 2026), $1.3 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.